| Product Name | Elacestrant (Synonyms: RAD1901) | 
|---|---|
| CAS | 722533-56-4 | 
| Formula | C30H38N2O2 | 
| MW | 458.63 | 
| MDL | MFCD30532693 | 
| Appearance | White to off-white powder | 
| Storage condition | 4°C, sealed storage, away from moisture and light | 
| Size | Availability | Price(USD) | VIP Price (USD) | Quantity | 
|---|---|---|---|---|
| 1 mg | 3-5 days | $156.00 | Visible after login | |
| 2 mg | 3-5 days | $246.00 | Visible after login | |
| 5 mg | 3-5 days | $456.00 | Visible after login | 
| Product Name | Elacestrant (Synonyms: RAD1901) | 
|---|---|
| CAS | 722533-56-4 | 
| Formula | C30H38N2O2 | 
| MW | 458.63 | 
| MDL | MFCD30532693 | 
| Appearance | White to off-white powder | 
| Storage condition | 4°C, sealed storage, away from moisture and light | 
Elacestrant (RAD1901) is a potent oral SERD with IC50s of 48 nM for ERα and 870 nM for ERβ. It effectively inhibits the growth of ER+ breast cancer cell lines both in vitro and in vivo, showcasing its significant bioactivity in targeting estrogen receptor pathways crucial for cancer cell proliferation.
PMID: 26164151 PMCID: PMC4560273 DOI: 10.1097/CAD.0000000000000271
PMID: 28473534 DOI: 10.1158/1078-0432.CCR-16-2561